# A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

> **NCT00699517** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 355 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** OMBRABULIN (AVE8062)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00699517
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 355 (ACTUAL)
- **Last updated:** 2015-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00699517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00699517, "A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00699517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*